Erratum: Ranibizumab for the treatment of wet AMD: a summary of real-world studies

被引：0
|
作者：
V Chong
机构：
来源：
Eye | 2016年 / 30卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Correction to: Eye (2016) 30, 270–286; doi:10.1038/eye.2015.217; published online 4 December 2015 This article was originally published under a standard License to Publish, but has now been made available under a CC BY 4.0 license. The PDF and HTML versions of the paper have been modified accordingly.
引用
收藏
页码：1526 / 1526
相关论文
共 50 条
  • [1] Ranibizumab for the treatment of wet AMD: a summary of real-world studies
    Chong, V.
    [J]. EYE, 2016, 30 (02) : 270 - 286
  • [2] Ranibizumab for the treatment of wet AMD: a summary of real-world studies
    V Chong
    [J]. Eye, 2016, 30 : 270 - 286
  • [3] Ranibizumab for the treatment of wet AMD: a summary of real-world studies (vol 30, pg 270, 2016)
    Chong, V.
    [J]. EYE, 2016, 30 (11) : 1526 - 1526
  • [4] Real-World Results of Aflibercept versus Ranibizumab for the Treatment of Exudative AMD Using a Fixed Regimen
    Providencia, Joana
    Rodrigues, Tiago M.
    Oliveira, Mariana
    Bernardes, Joao
    Marques, Joao Pedro
    Murta, Joaquim
    Silva, Rufino
    [J]. BIOMED RESEARCH INTERNATIONAL, 2018, 2018
  • [5] Intravitreal Injections of Ranibizumab (Lucentis) for Treatment of Wet AMD
    Smirnov, E.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [6] Real-world visual acuity outcomes between ranibizumab and aflibercept in treatment of neovascular AMD in a large US data set
    Lotery, A.
    Griner, R.
    Ferreira, A.
    Milnes, F.
    Dugel, P.
    [J]. EYE, 2017, 31 (12) : 1697 - 1706
  • [7] Real-world outcomes of Ranibizumab treatment for Diabetic Macular Oedema
    Patrao, Namritha Valerie
    Antao, Sheelah
    Sim, Dawn A.
    Sivaprasad, Sobha
    Andrews, Richard
    Hamilton, Robin
    Egan, Catherine A.
    Tufail, Adnan
    Hykin, Philip G.
    Rajendram, Ranjan
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [8] Real-world visual acuity outcomes between ranibizumab and aflibercept in treatment of neovascular AMD in a large US data set
    A Lotery
    R Griner
    A Ferreira
    F Milnes
    P Dugel
    [J]. Eye, 2017, 31 : 1697 - 1706
  • [9] Trends in Real-World Neovascular AMD Treatment Outcomes in the UK
    Mehta, Hemal
    Kim, Leah N.
    Mathis, Thibaud
    Zalmay, Pardis
    Ghanchi, Faruque
    Amoaku, Winfried M.
    Kodjikian, Laurent
    [J]. CLINICAL OPHTHALMOLOGY, 2020, 14 : 3331 - 3342
  • [10] FREQUENCY OF RANIBIZUMAB INJECTIONS FOR THE TREATMENT OF WET AGE-RELATED MACULAR DEGENERATION: CANADIAN REAL-WORLD UTILIZATION DATA
    Davies, B.
    Gonder, J.
    Blouin, J.
    Zaour, N.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A575 - A575
12345